Home › beta-Thalassemia
beta-Thalassemia clinical trials recruiting in the U.S.
15 studies for beta-Thalassemia are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT03937817ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
RecruitingPhase 1/2
Ages 18 to 40 · All sexes · Updated Sep 23, 2026 · NCT06364774Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
RecruitingPhase 1/2
Ages 4 to 65 · All sexes · Updated Sep 4, 2026 · NCT07599176T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
RecruitingPhase 1/2
Ages 5 to 40 · All sexes · Updated Aug 13, 2026 · NCT03653338Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Jul 10, 2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
RecruitingPhase 2
Ages 2 to 50 · All sexes · Updated Jun 3, 2026 · NCT05736419MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
RecruitingPhase 2
Up to age 60 · All sexes · Updated Apr 6, 2026 · NCT05735717Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RecruitingPhase 3
Ages 12 to 35 · All sexes · Updated Mar 23, 2026 · NCT05477563Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RecruitingPhase 1
Ages 13 to 40 · All sexes · Updated Feb 3, 2026 · NCT06647979Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
RecruitingObservational study
2 Months – 60 Years · All sexes · Updated Jan 13, 2026 · NCT04528355Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT01245179Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
RecruitingPhase 2
2 Months – 55 Years · All sexes · Updated Dec 15, 2025 · NCT01962415AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
RecruitingPhase 2
1 Day – 30 Years · All sexes · Updated Aug 8, 2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
RecruitingObservational study
All ages · All sexes · Updated Feb 11, 2025 · NCT06271512Study of the Role of Genetic Modifiers in Hemoglobinopathies
RecruitingObservational study
Ages 2 and older · All sexes · Updated Mar 20, 2024 · NCT05799118From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.